Comparison of Total Oxidant and Total Antioxidant Capacities in Low-Flow and High-Flow General Anesthesia

NCT ID: NCT05590312

Last Updated: 2025-01-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-01

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to determine whether low-flow anesthesia has a positive contribution to the total oxidant/antioxidant balance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General anesthesia is a complex physiological state characterized by reversible loss of consciousness, whole-body analgesia, amnesia, and muscle relaxation. Modern anesthesia devices used for patients under general anesthesia are semi-closed rebreathing systems. The fresh gas flow entering these closed systems is determined by the anesthetists.

The term low-flow anesthesia is used to describe inhalation anesthesia techniques that are administered with a semi-closed rebreathing system and have a rebreathing rate of at least 50%. The high standard of anesthesia machines, the existence of monitors that analyze the anesthetic gas composition continuously and in detail, and the increase in knowledge about the pharmacodynamics and pharmacokinetics of inhalation anesthetics have greatly facilitated the safe administration of low-flow anesthesia. The terminology associated with low-flow anesthesia techniques may be based on rebreathing rate or fresh gas flow rate. The most important factor determining the rebreathing rate is the fresh gas flow rate. If the fresh gas flow rate is reduced to less than 2 L/min when using modern rebreathing systems, low-flow anesthesia can be mentioned for most patients.

Oxidative stress is accepted as a pathological mechanism. Oxidative stress is a state of oxidative damage that occurs when the critical balance between free radical production and antioxidant defense systems is disrupted. Oxidative stress is beneficial in certain physiological conditions. For example, it can strengthen biological defense mechanisms during appropriate physical exercise and ischemia. However, its benefits are limited to these specific situations, and in many other cases, high levels of oxidative stress cause cell death and thus cell and tissue damage via necrotic or apoptotic mechanisms. If damage continues at the cell and tissue level, it causes the onset and progression of various organ damage and diseases.

Aim: In low-flow anesthesia applications, the amount of inspired oxygen is expected to be low due to keeping the gas supplied to the system low. Therefore, in this study, it will be investigated whether low-flow anesthesia has a positive contribution to the total oxidant/antioxidant balance.

Method: A total of 72 patients undergoing general anesthesia who meet the inclusion criteria and signed informed consent will be included in the study. Vitamin D, albumin, C-reactive protein (CRP), Total Antioxidant (TAS) and Total Oxidant (TOS) levels will be determined in the blood samples taken from all volunteers routinely before the operation. Basal peak heart rate (HR), peripheral oxygen saturation (SpO2), systolic (SBP) and diastolic blood pressure (DBP), end-tidal carbon dioxide (ETCO2), body temperature and processed EEG values will be recorded. All measurements will be recorded and repeated at 5 minute intervals throughout the operation. Volunteers will be randomly divided into 2 groups as low flow group (D) and high flow group (Y). Fresh gas flow of 1 L/min to D group and 4 L/min to Y group will be administered. During the operation, the processed EEG values of all patients will be held between 40-60 and it will be ensured that they are at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again in the blood samples taken for routine tests performed at the end of operation and postoperatively within 6-24 hours after the end of operation, and these values will be compared with the values obtained before the operation.

Statistical Analysis: It is planned to use 'Independent Samples t test' or 'Mann-Whitney U test' in comparison of the groups, depending on the distribution of the data. Chi-square tests will be used to examine the relationships between categorical variables. 'Repeated Measure ANOVA' will be used in the evaluation of repeated measurements. Correlations between continuous variables will be analyzed by Pearson or Spearman correlation analysis, depending on the distribution of the data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oxidative Stress Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Flow Group - Group D

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones.

general anesthesia

Intervention Type OTHER

All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.

High Flow Group - Group Y

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones.

general anesthesia

Intervention Type OTHER

All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

general anesthesia

All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18 years and younger than 60 years of age who will be operated under general anesthesia
* Patients in I, II risk groups according to the American Society of Anesthesiologists (ASA) classification

Exclusion Criteria

* ASA III and above patients,
* Patients for whom Intensive Care Unit (ICU) indication is required
* Chronic obstructive pulmonary disease,
* Personal or family history of malignant hyperthermia,
* Morbid obesity,
* Alcohol or drug dependency,
* Having a history of liver or kidney disease,
* Having coronary artery disease or heart failure,
* Having significant anemia or hemoglobinopathy,
* Hypotension, hypovolemia, sepsis.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duzce University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Özlem Ersoy Karka

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Özlem Ersoy Karka

Role: PRINCIPAL_INVESTIGATOR

Düzce University Faculty of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duzce University Faculty of Medicine

Düzce, Düzce, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

drozlemersoy3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.